The manufacturer of the specific Lenvaxen product is Everest Pharmaceuticals Ltd. It would be misleading to identify a company as the Lenvaxen manufacturer without documentary evidence from the product packaging, authorization record or official manufacturer documentation.
Who developed lenvatinib?
Lenvatinib itself was discovered and developed by Eisai. Eisai’s published information identifies lenvatinib as an in-house discovery and development program.
Reference product
The major reference brand is LENVIMA. In Europe, the same active substance is also marketed as Kisplyx for specified renal-cell-carcinoma uses.
Manufacturer versus originator
These terms should not be treated as interchangeable:
- Originator/developer: company that developed the active pharmaceutical substance or reference medicine.
- Manufacturer: company responsible for manufacturing a specific product.
- Brand owner: entity owning a particular commercial brand.
- Marketing authorization holder: entity legally responsible for a medicinal product authorization in a jurisdiction.
- Distributor: company involved in distribution.
- Supplier: party supplying a product through a particular commercial channel.